An ‘off-the-shelf’ fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies

T cell malignancies represent a group of hematologic cancers with high rates of relapse and mortality in patients for whom no effective targeted therapies exist. The shared expression of target antigens between chimeric antigen receptor (CAR) T cells and malignant T cells has limited the development...

Descripción completa

Detalles Bibliográficos
Autores principales: Cooper, Matthew L., Choi, Jaebok, Staser, Karl, Ritchey, Julie K., Devenport, Jessica M., Eckardt, Kayla, Rettig, Michael P., Wang, Bing, Eissenberg, Linda G., Ghobadi, Armin, Gehrs, Leah N., Prior, Julie L., Achilefu, Samuel, Miller, Christopher A., Fronick, Catrina C., O’Neal, Julie, Gao, Feng, Weinstock, David M., Gutierrez, Alejandro, Fulton, Robert S., DiPersio, John F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102094/
https://www.ncbi.nlm.nih.gov/pubmed/29483708
http://dx.doi.org/10.1038/s41375-018-0065-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102094/
https://www.ncbi.nlm.nih.gov/pubmed/29483708
http://dx.doi.org/10.1038/s41375-018-0065-5

Ejemplares similares